ClinicalTrials.Veeva

Menu

Restoring Neural Oscillatory Communication in Developmental Dyslexia

I

IRCCS Ospedale San Raffaele

Status

Completed

Conditions

Developmental Dyslexia

Treatments

Device: Parietal tACS combined with visuo-attentional training
Device: Sham (placebo) tACS combined with phonics training
Device: Sham (placebo) tACS combined with visuo-attentional training

Study type

Interventional

Funder types

Other

Identifiers

NCT05583136
NeOsReDy-01

Details and patient eligibility

About

Developmental dyslexia (DD) is a multifactorial disorder that hampers the education of about 10% of individuals across cultures and is associated to both phonological and visual deficits. The latter have been linked to a deficit in the magnocellular-dorsal (M-D) visual stream, that has a critical role in guiding the activity of ventral visual stream areas where letters identity is extracted. Here, we will test the efficacy of transcranial alternate current stimulation (tACS) of the M-D stream combined with reading trainings in adult participants with DD, assessing the neurophysiological underpinnings of these new trainings with EEG and fMRI/DTI.

Enrollment

78 patients

Sex

All

Ages

18 to 35 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Adult patient (age between 18 and 35)
  • Official Diagnosis of Developmental Dyslexia (DD)
  • Normal or corrected-to-normal vision and hearing
  • Normal motor skills

Exclusion criteria

  • Participants that cannot sign the consent form
  • Participants unable to read or understand and correctly complete the procedures foreseen by the study
  • Participants with a diagnosis or personal history of epilepsy or patients with a positive family history of epilepsy
  • Pregnant or breastfeeding patients
  • Participants with major psychiatric or neurological disorders and/or currently in psychopharmacological treatments.
  • Participants with metal implants in the brain, pacemakers, brain stimulators, cochlear implants.
  • Participants with claustrophobia (only for fMRI)

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

78 participants in 3 patient groups

Group DD1
Experimental group
Description:
tACS + visuo-attentional training
Treatment:
Device: Parietal tACS combined with visuo-attentional training
Group DD2
Active Comparator group
Description:
Sham (placebo) tACS + visuo-attentional training
Treatment:
Device: Sham (placebo) tACS combined with visuo-attentional training
Group DD3
Active Comparator group
Description:
Sham (placebo) tACS + phonics training
Treatment:
Device: Sham (placebo) tACS combined with phonics training

Trial contacts and locations

1

Loading...

Central trial contact

Luca Ronconi, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems